Acorda Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Acorda Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q2 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Other Assets, Current for the quarter ending March 31, 2024 was $2.45M, a 39.9% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.45M -$1.62M -39.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.77M -$995K -14.7% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $5.44M +$2.73M +101% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $5.15M +$298K +6.14% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.07M +$2.21M +119% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $6.77M +$5.77M +577% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.71M +$537K +24.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4.85M +$3.27M +208% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.86M -$444K -19.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $999K -$578K -36.7% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.17M -$14.3M -86.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.58M -$1.33M -45.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.3M -$1.99M -46.3% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $1.58M -$1.98M -55.7% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $16.5M +$12.5M +311% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $2.91M +$569K +24.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $4.29M -$3.46M -44.7% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $3.56M -$6.63M -65.1% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $4.01M -$2.8M -41.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.34M +$335K +16.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $7.75M +$6.29M +433% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $10.2M +$8.21M +414% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $6.8M -$597K -8.07% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.01M -$2.74M -57.7% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $1.45M -$3.11M -68.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.98M -$3.78M -65.6% Dec 31, 2017 10-K 2020-02-28
Q3 2017 $7.4M +$2.54M +52.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $4.74M -$872K -15.5% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $4.57M -$12.5M -73.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $5.76M -$2.2M -27.6% Dec 31, 2016 10-K/A 2018-03-09
Q3 2016 $4.86M -$2.7M -35.7% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $5.62M -$2.55M -31.2% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $17.1M +$10.1M +144% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $7.96M +$635K +8.67% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $7.56M -$2.81M -27.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $8.17M -$1.96M -19.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $7M -$732K -9.47% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $7.32M -$1.14M -13.4% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $10.4M +$3.82M +58.2% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $10.1M -$635K -5.9% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $7.73M -$3.33M -30.1% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $8.46M -$1.09M -11.4% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $6.56M -$2.93M -30.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $10.8M +$1.35M +14.3% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $11.1M +$280K +2.6% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $9.55M +$2.56M +36.6% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $9.48M +$1.7M +21.9% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $9.41M +$5.08M +117% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $10.8M +$6.44M +148% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $6.99M +$3.25M +87.1% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $7.78M +$4.52M +139% Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $4.33M +$758K +21.2% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $4.34M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $3.73M Dec 31, 2010 10-K 2012-02-28
Q3 2010 $3.26M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $3.57M Jun 30, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.